CONCERTO/CONCERTO II, CONSULTA, MAXIMO II, PROTECTA/PROTECTA XT
FDA premarket approval P010031/S285 · decided 2011-12-23
Approval details
- PMA number
- P010031
- Supplement
- S285
- Supplement type
- 30-Day Notice
- Supplement reason
- Process Change - Manufacturer/Sterilizer/Packager/Supplier
- Trade name
- CONCERTO/CONCERTO II, CONSULTA, MAXIMO II, PROTECTA/PROTECTA XT
- Applicant
- Medtronic Cardiac Rhythm Disease Management
- Date received
- 2011-11-25
- Decision date
- 2011-12-23
- Days to decision
- 28 days
- Decision code
- OK30
- Advisory committee
- Cardiovascular
- Expedited review
- No
- Location
- Mounds View, MN
- Statement
- IMPLEMENTATION OF A MANUFACTURING OPERATIONS CONSOLIDATION AND EQUIPMENT CHANGE AT AN APPROVED COMPONENT SUPPLIER.
Class III intelligence, same tools
PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.